[Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)]. 1981

F Schumm, and J Dichgans, and E Zeller

Tetrabenazine (50-150 mg/day) was a moderate to excellent efficacy in each of six patients with severe spontaneous oral dyskinesia. Slight akinesia, rigidity, and transient disorientation were occasional side effects that could easily be controlled and were tolerated by the patient in view of the lasting amelioration of this debilitating symptom. When tetrabenazine was administered for blepharospasm, only two of six cases showed partial improvement with more severe side effects.

UI MeSH Term Description Entries
D008297 Male Males
D008410 Masticatory Muscles Muscles arising in the zygomatic arch that close the jaw. Their nerve supply is masseteric from the mandibular division of the trigeminal nerve. (From Stedman, 25th ed) Masticatory Muscle,Muscle, Masticatory,Muscles, Masticatory
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D001764 Blepharospasm Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle. Blepharospasms
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001480 Basal Ganglia Diseases Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA. Extrapyramidal Disorders,Basal Ganglia Disorders,Lenticulostriate Disorders,Basal Ganglia Disease,Basal Ganglia Disorder,Extrapyramidal Disorder,Lenticulostriate Disorder

Related Publications

F Schumm, and J Dichgans, and E Zeller
November 1974, Archives of neurology,
F Schumm, and J Dichgans, and E Zeller
April 1976, No to shinkei = Brain and nerve,
F Schumm, and J Dichgans, and E Zeller
October 2001, Progress in neuro-psychopharmacology & biological psychiatry,
F Schumm, and J Dichgans, and E Zeller
January 1984, European archives of psychiatry and neurological sciences,
F Schumm, and J Dichgans, and E Zeller
September 1980, Postgraduate medical journal,
F Schumm, and J Dichgans, and E Zeller
January 1981, Leber, Magen, Darm,
F Schumm, and J Dichgans, and E Zeller
November 1980, No to shinkei = Brain and nerve,
F Schumm, and J Dichgans, and E Zeller
April 2011, The Annals of pharmacotherapy,
F Schumm, and J Dichgans, and E Zeller
October 1971, British medical journal,
F Schumm, and J Dichgans, and E Zeller
April 1973, The American journal of psychiatry,
Copied contents to your clipboard!